SRx Health Solutions Inc. (SRXH)

NYSEAMERICAN: SRXH · Real-Time Price · USD

0.1260

+0.0048 (3.96%)

At close: Jun 10, 2026, 4:00 PM EDT

0.1241

-0.0019 (-1.51%)

After-hours: Jun 10, 2026, 6:47 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023
Consumer Products	6.53M	-	-
Pharmacy and Sale of Prescription Drugs	-	-	118.38M
Clinical Trials	-	-	1.04M
Total	6.53M	-	119.42M

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
United States	5.51M	-	-	-
Canada	-	-	119.42M	93.18M
Canada Growth	-	-	28.16%	-
Taiwan	833.00K	-	-	-
Other	196.00K	-	-	-
Total	6.53M	-	119.42M	93.18M
Total Growth	-	-	28.16%	-

Source: S&P Global Market Intelligence.